Disparities in pediatric obesity in the United States

Youfa Wang1

  • 1Center for Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. ywang@jhsph.edu

Insights

Childhood obesity in the U.S. has increased, with significant disparities among ethnic groups and regions. Native American children face the highest rates, while Asian children have the lowest, highlighting the need for targeted interventions.

Area of Science:

  • Public Health
  • Pediatrics
  • Epidemiology

Background:

  • Childhood obesity prevalence in the U.S. has risen significantly since the late 1970s.
  • Body fatness measures indicate increased adiposity and central obesity among U.S. children over time.
  • Existing data reveal complex, substantial disparities in obesity prevalence and trends across different groups and regions.

Purpose of the Study:

  • To describe the disparities in the U.S. childhood obesity epidemic.
  • To analyze trends in body fatness measures and their distribution over time.
  • To identify specific population groups and regions disproportionately affected by childhood obesity.

Main Methods:

  • Analysis of recent, nationally representative data on childhood overweight and obesity.
  • Examination of trends in body fatness measures, including body mass index and waist circumference.
  • Stratification of data by ethnicity, age group, geographic region, and socioeconomic status.

Main Results:

  • Native American children exhibit the highest obesity prevalence, while Asian children have the lowest.
  • Preschool-aged children show lower obesity prevalence compared to older children.
  • Significant regional variations exist, with some areas having twice the prevalence of others; low socioeconomic status is linked to obesity in specific groups, like white children.

Conclusions:

  • The U.S. childhood obesity epidemic is characterized by significant and complex disparities.
  • Targeted, vigorous interventions are crucial to promote healthy lifestyles and reduce obesity-related health inequities.
  • Addressing the multifaceted etiology of obesity requires tailored strategies for diverse populations and regions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...